Mr. John Miller reports

THC BIOMED ANNOUNCES INCLUSION IN THE CSE COMPOSITE INDEX

THC Biomed Intl Ltd. has been included in the CSE Composite Index as of market close on July 5, 2023.

The CSE Composite Index is administered by Solactive AG, a leading index provider serving 350 clients globally across Europe, the Americas and Asia. The index follows a set of robust policies and procedures, published on the Canadian Securities Exchange website, which are maintained by an index committee. This committee has the sole discretion to determine how policies and procedures are interpreted and can update them over time if deemed necessary.

"Our inclusion in the CSE Composite Index is a testament to our steady growth, financial performance and commitment to our stakeholders," said THC Biomed chief executive officer John Miller. "We are honoured to join the ranks of other esteemed companies on this index and are excited about the increased visibility and potential enhanced liquidity this development may bring." The inclusion in the CSE Composite Index marks a significant milestone for THC Biomed and serves as further recognition of the company's commitment to cultivating and supplying high-quality cannabis products for both the medical and recreational sectors.

About THC Biomed Intl Ltd.

THC Biomed is a Cannabis Act licensed producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The company is a pioneer in the cannabis industry, leading in scientific research and the development of products and services, with patient safety as a guiding principle.

We seek Safe Harbor.